BACKGROUND Interstitial lung disease (ILD) is the leading cause of morbidity and mortality
in patients with systemic sclerosis (SSc); however, prognostication of SSc-associated ILD (…

Background Systemic sclerosis (SSc) is an autoimmune disorder characterized by fibrosis
of the skin and internal organs. Pathologic conversion of regulatory T (Treg) cells into …

Objectives The Scleroderma Patient-centered Intervention Network (SPIN) Cohort is a web-based
cohort designed to collect patient-reported outcomes at regular intervals as a …

Background: There has been a growing recognition of the need for information about
objective abnormalities in people with the fibromyalgia syndrome [FMS] and for an integrated …

… BDT, LK, RSH, SP, SJB, JV, and ABenedetti were responsible for study concept and design.
BDT, LK, RSH, SP, SH, ABourgeault, LT, SJB, JV, and ABenedetti were responsible for …

BACKGROUND Mortality risk prediction tools have been developed in idiopathic pulmonary
fibrosis, however, it is unknown whether these models accurately estimate mortality in …

Objective Contagious disease outbreaks and related restrictions can lead to negative
psychological outcomes, particularly in vulnerable populations at risk due to pre-existing medical …

Background Connective tissue disease-associated interstitial lung disease (CTD-ILD) is
associated with reduced quality of life and poor prognosis. Prior studies have not identified a …

Exploration of cytokine levels in systemic sclerosis-associated interstitial lung disease (SSc-ILD)
and idiopathic pulmonary fibrosis (IPF) is needed to find common and diverse …

Cardiac tamponade in systemic sclerosis is rare. We report four cases of SSc with
hemodynamically significant pericardial effusions associated with pulmonary arterial hypertension, …